COMPPARE Newsroom Prostate cancer research news
The latest information for patients.
prostate Cancer News from around the world
Health News from The NIH
Sensor monitors bladder fullness
Researchers developed a wireless implantable device that can monitor bladder filling and emptying in real time and send data to a smartphone.
Rejuvenating the immune system by depleting certain stem cells
Researchers found that depleting certain stem cells improved the immune systems of aged mice.
Gut bacteria may reduce cholesterol and lower heart disease risk
Researchers pinpointed gut bacteria that affect levels of cholesterol and other compounds linked to heart disease.
Gum disease-related bacteria tied to colorectal cancer
Scientists identified a specific subtype of bacteria implicated in gum disease that may promote the growth of colorectal tumors.
Health News from UFHPTI
The UF Health Proton Therapy Institute creates an environment of healing
In the past year, the UF Health Proton Therapy Institute has strived to create an environment of healing for all its patients during cancer treatment.
Current evidence on proton therapy for head and neck squamous cell carcinoma
Cancer specialists who treat cancer of the head and neck have come together to review the current evidence on the use of proton therapy treatment for patients with head and…
Choosing the right cancer treatment center
When faced with a cancer diagnosis, finding cancer care that is the best becomes a top-priority for individuals and their loved ones.
Advances in lung cancer treatment: the power of five radiation treatments
In the realm of oncology, treating lung cancer has long been a complex challenge due to the delicate nature of the surrounding structures and the potential for collateral damage.
News from COMPPARE
New Patient Surveys to Assist in Designing the…
In early June, COMPPARE Coordinators administered over 500 surveys to participants. The purpose of the surveys is to guide the design of the next…
What’s Next for COMPPARE?
Patient accrual has closed. Now, it’s up to participants to continue to complete COMPPARE’s Quality of Life and Side Effects Follow-up…
COMPPARE Completes Patient Enrollment
After four years and 2,524 enrolled patients, the COMPPARE team officially closed patient accrual to the study on October 31, 2022 at 11:59 p.m…
Social media
